Seto M, Osada H, Ueda R, Ito C, Iwaki O, Oyama A, Suchi T, Takahashi T
Laboratory of Chemotherapy, Aichi Cancer Center Hospital.
Jpn J Cancer Res. 1991 Jan;82(1):65-71. doi: 10.1111/j.1349-7006.1991.tb01747.x.
Breakpoints of a lymphoma case with bcl-2 gene rearrangement that did not show comigration of immunoglobulin (Ig) heavy chain joining (JH) fragment were cloned. Sequence analysis revealed that the translocation broke the 3' side of the Ig heavy chain diversity (DH) segment at the heptamer recombination signal and each end was ligated to the bcl-2 locus. Since Southern blot demonstrated that both alleles of JH were rearranged, this translocation was suggested to have occurred at the step of VH-DH, or DH-DHJH recombination, one step later than that of DH-JH recombination where the common pattern of bcl-2 rearrangement generally occurs. Cases that showed comigration with JH fragment were also studied by polymerase chain reaction with 5' bcl-2 oligomer and 3' JH consensus anti-sense oligomer since it has been demonstrated that bcl-2 translocation at the major breakpoint clustering region (mbr) in American cases clusters within an about 150 bp region in the mbr. The results demonstrated that four out of five cases studied were amplified, indicating that the same clustering mechanism exists for Japanese cases. The present study, together with our previous report on Ig kappa-bcl-2, indicated that bcl-2 translocation in Japanese B cell lymphomas might occur at a later stage of B cell development, as compared with that in American cases. Less involvement of bcl-2 in Japanese B cell lymphoma may also be in part explainable by low susceptibility to bcl-2 rearrangement at the step of DH-JH recombination.
克隆了1例bcl-2基因重排的淋巴瘤病例的断点,该病例未显示免疫球蛋白(Ig)重链连接(JH)片段的共迁移。序列分析显示,易位在七聚体重组信号处断裂了Ig重链多样性(DH)区段的3'端,且两端均连接至bcl-2基因座。由于Southern印迹显示JH的两个等位基因均发生了重排,因此提示该易位发生在VH-DH或DH-DHJH重组步骤,比通常发生bcl-2重排常见模式的DH-JH重组步骤晚一步。对于显示与JH片段共迁移的病例,也使用5'bcl-2寡聚体和3'JH共有反义寡聚体通过聚合酶链反应进行了研究,因为已经证明美国病例中主要断点簇集区域(mbr)的bcl-2易位聚集在mbr内约150 bp的区域内。结果显示,所研究的5例病例中有4例得到扩增,表明日本病例存在相同的簇集机制。本研究与我们之前关于Igκ-bcl-2的报告一起表明,与美国病例相比,日本B细胞淋巴瘤中的bcl-2易位可能发生在B细胞发育的后期。日本B细胞淋巴瘤中bcl-2参与较少,也可能部分是由于在DH-JH重组步骤中对bcl-2重排的易感性较低。